Decreased Growth with Serotonin Reuptake Inhibitors

J Gordon Millichap

doi:10.15844/pedneurbriefs-16-8-12

Decreased Growth with Serotonin Reuptake Inhibitors

Pediatric Neurology Briefs

Volume 16 (2002): Issue 8

By: J Gordon Millichap

Open Access

|Aug 2002

Abstract

Growth and growth hormone secretion were evaluated in 4 children (3 boys), aged 11.6 to 13.7 years, treated with selective serotonin reuptake inhibitors (SSRIs) for obsessive compulsive disorder or Tourette syndrome, at Schneider Children’s Medical Center of Israel, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv.

References

Weintrob N Cohen D Klipper-Aurbach Y Zadik Z Dickerman Z Decreased growth during therapy with selective serotonin reuptake inhibitors Arch Pediatr Adolesc Med 2002 Jul 156 7 696 701 10.1001/archpedi.156.7.696 12090838
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-16-8-12 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 64 - 64

Published on: Aug 1, 2002

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Selective Serotonin Reuptake Inhibitors,

Pubertal Progression,

Hypothalamic-Pituitary Function

© 2002 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 16 (2002): Issue 8